This was carried out in women with PCOS, a disease which can lead to reduced sensitivity to insulin in the body
Major Ingredients Water, Dibutyl Adipate, Propanediol, Diethylamino Hydroxybenzoyl Hexyl Benzoate, Caprylyl Methicone, Ethylhexyl Triazone, Polymethylsilsesquioxane, Methylene Bis-Benzotriazolyl Tetramethylbutylphenol, Butyloctyl Salicylate, Diethylhexyl Butamido Triazone, Glycerin, 1,2-Hexanediol, Butylene Glycol, Pentylene Glycol, Vinyl Dimethicone/Methicone Silsesquioxane Crosspolymer, Poly C10-30 Alkyl Acrylate, Decyl Glucoside, Polyglyceryl-3 Methylglucose Distearate, Tromethamine, Behenyl Alcohol, Carbomer, Centella Asiatica Leaf Water, Niacinamide, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Polyacrylate Crosspolymer-6, Sodium Stearoyl Glutamate, Stearyl Alcohol, Ethylhexylglycerin, Arachidyl Alcohol, Glutathione, Xanthan Gum, Cetyl Alcohol, Dipropylene Glycol, Squalane, Asiaticoside, Madecassic Acid, Asiatic Acid, Sodium Hyaluronate, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hippophae Rhamnoides Fruit Extract, Hydrolyzed Collagen, Beta-Glucan, Caprylyl Glycol, Nelumbium Speciosum Flower Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract Ingredients subject to change at manufacturer's discretion
This happens because Sermorelin can cause blood vessels to widen (dilate), which increases the blood flow to the skin
February 23, 2026: New Weight Loss Drug Fails to Outperform Zepbound in Clinical Trial Zepbound was not outperformed in a clinical trial of a competitors new GLP-1 weight loss drug formulation
